C000198377 Fees and Costs — iShares Evolved U.S. Healthcare Staples ETF
Data updated: 2022-10-12
The net expense ratio is 0.18%. There are no sales loads or redemption fees. In fiscal 2022 the fund paid $226 in broker commissions, 0.0006% of average net assets, and portfolio turnover was 2%.
C000198377 Fees and Expenses
Annual operating expenses and sales charges of C000198377. Prospectus, as of November 30, 2021.
| Annual operating expenses | |
|---|---|
| Management fee | 0.18% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.18% |
| Fee waiver | — |
| Net expense ratio | 0.18% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
C000198377 Costs Over Time
On $10,000 invested in C000198377, assuming 5% a year before costs, total costs come to $115 over 5 years, cutting the return by 0.19% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.18%) | $19 | $59 | $104 |
| Trading costs (broker commissions) | $0 | $0 | $0 |
| Lost growth on money paid in costs | $0 | $3 | $10 |
| Total costs | $19 | $63 | $115 |
| Value after costs | $10,481 | $11,514 | $12,648 |
| Impact on return, per year | 0.19% | 0.19% | 0.19% |
C000198377 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending July 31, 2022.
- Explicit cost rate (commissions ÷ average net assets): 0.0006%
- Total broker commissions: $226
- Bought from dealers (principal trades, not a cost): $14.1M
- Portfolio turnover (prospectus): 2%
- Securities on loan, average value: $136K
- Net income from securities lending: $258 (0.001% of average net assets)
C000198377 Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Morgan Stanley & Co. LLC | $147 | 64.95% |
| Citigroup Global Markets Inc. | $60 | 26.54% |
| UBS Securities LLC | $19 | 8.51% |
C000198377 Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| National Securities Clearing Corporation | $9.8M | 70.96% |
| BlackRock Funds III - BlackRock Cash Funds: Treasury | $4.0M | 29.04% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.